QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 1 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $139,949,000 | +412.5% | 1,521,186 | +256.5% | 0.15% | +377.4% |
| Q1 2014 | $27,305,000 | +2.6% | 426,652 | -13.4% | 0.03% | +14.8% |
| Q4 2013 | $26,615,000 | -15.8% | 492,863 | -9.5% | 0.03% | -28.9% |
| Q3 2013 | $31,595,000 | +33.0% | 544,756 | +4.2% | 0.04% | +26.7% |
| Q2 2013 | $23,750,000 | – | 522,678 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
| Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
| Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
| Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
| RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
| CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
| Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
| Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |